Bioventus (BVS) Non-Current Assets (2020 - 2026)

Bioventus (BVS) has reported Non-Current Assets for 7 consecutive years, with $415.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non-Current Assets fell 3.65% year-over-year to $415.8 million; the trailing twelve-month figure through Jun 2026 stood at $1.6 billion (down 8.28% YoY), and the FY2025 full-year result was $410.7 million, down 9.2% from the prior year.
• Non-Current Assets grew to $415.8 million in Q2 2026 per BVS's latest filing, from $400.7 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $1.1 billion in Q4 2022 and bottomed at $400.7 million in Q1 2026.
• Historically, Non-Current Assets has averaged $601.5 million across 5 years, with a median of $505.8 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Non-Current Assets jumped 175.73% in 2022, then slumped 50.65% in 2023.
• Over 5 years, Non-Current Assets stood at $1.1 billion in 2022, then plunged by 50.65% to $542.9 million in 2023, then declined by 16.68% to $452.3 million in 2024, then declined by 9.2% to $410.7 million in 2025, then advanced by 1.24% to $415.8 million in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $415.8 million, $400.7 million, and $410.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.